Rubicon Research

82
Strong Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
1,555.25
22.2 (1.45%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 1.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
No of Months
12
12
12
Operating Income
1,753.00
1,284.00
853.00
Less :Inter divisional transfers
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
Net Sales
1,753.00
1,284.00
853.00
Expenditure (Ex Depriciation)
Stock Adjustments
-150.00
-157.00
-53.00
Raw Materials Consumed
706.00
532.00
332.00
Power & Fuel Cost
25.00
20.00
18.00
Employee Cost
256.00
211.00
125.00
Operating Expenses
69.00
66.00
41.00
General and Administration Expenses
-1.00
-1.00
-1.00
Selling and Distribution Expenses
163.00
167.00
91.00
Cost of Software developments
0.00
0.00
0.00
Miscellaneous Expenses
17.00
1.00
11.00
Expenses Capitalised
0.00
0.00
0.00
Total Expenditure
1,353.00
1,020.00
699.00
Operating Profit (PBDIT) excl Other Income
400.00
264.00
154.00
Other Income
7.00
3.00
18.00
Operating Profit (PBDIT)
407.00
267.00
173.00
Interest
42.00
36.00
31.00
Profit before Depriciation and Tax
365.00
231.00
141.00
Depreciation
45.00
36.00
38.00
Profit Before Taxation & Exceptional Items
320.00
194.00
102.00
Exceptional Income / Expenses
0.00
0.00
0.00
Profit Before Tax
320.00
194.00
102.00
Provision for Tax
73.00
60.00
11.00
Profit After Tax
246.00
134.00
91.00
Extraordinary Items
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
Profit Balance B/F
252.00
116.00
25.00
Profit Available for appropriations
498.00
250.00
116.00
Appropriations
498.00
250.00
116.00
Equity Dividend (%)
150.00%
2.00%
2.00%
Earnings Per Share
15.52
8.82
5.98
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 36.57% vs 50.40% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 51.46% vs 70.94% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 14.64% vs 17.66% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 83.64% vs 47.63% in Mar 2025

Compare Profit and Loss Results of Rubicon Research
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,753.00
1,006.00
747.00
74.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,753.00
1,006.00
747.00
74.25%
Expenditure (Ex Depriciation)
Stock Adjustments
-150.00
-17.00
-133.00
-782.35%
Raw Materials Consumed
706.00
569.00
137.00
24.08%
Power & Fuel Cost
25.00
30.00
-5.00
-16.67%
Employee Cost
256.00
83.00
173.00
208.43%
Operating Expenses
69.00
41.00
28.00
68.29%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
163.00
29.00
134.00
462.07%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
17.00
8.00
9.00
112.50%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,353.00
774.00
579.00
74.81%
Operating Profit (PBDIT) excl Other Income
400.00
232.00
168.00
72.41%
Other Income
7.00
16.00
-9.00
-56.25%
Operating Profit (PBDIT)
407.00
249.00
158.00
63.45%
Interest
42.00
6.00
36.00
600.00%
Profit before Depriciation and Tax
365.00
242.00
123.00
50.83%
Depreciation
45.00
26.00
19.00
73.08%
Profit Before Taxation & Exceptional Items
320.00
216.00
104.00
48.15%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
320.00
216.00
104.00
48.15%
Provision for Tax
73.00
55.00
18.00
32.73%
Profit After Tax
246.00
160.00
86.00
53.75%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
252.00
307.00
-55.00
-17.92%
Profit Available for appropriations
498.00
465.00
33.00
7.10%
Appropriations
498.00
465.00
33.00
7.10%
Equity Dividend (%)
150%
30%
120.00
Earnings Per Share
15.52
19.91
-4.39
-22.05%
Profit And Loss - Net Sales
Net Sales 1,753.96 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 36.57% vs 50.40% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 400.24 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 51.46% vs 70.94% in Mar 2025

Profit And Loss - Interest
Interest 42.17 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 14.64% vs 17.66% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 246.74 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 83.64% vs 47.63% in Mar 2025